Breast Cancer News
In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
PARP inhibitors, added to chemotherapy, show promise in treating metastatic triple-negative breast cancer.
Women with BRCA mutations believe prophylactic mastectomy will reduce their risk of developing breast cancer and decrease fears about developing the disease.
Tamoxifen, common antidepressants subject of two large studies that reached different conclusions when they examined the risk of breast cancer recurrence.
Tamoxifen, Raloxifene reduce breast cancer risk in postmenopausal women at increased risk for the disease, ASCO reports in updated guidelines.
The federal stimulus package may make health insurance coverage more affordable if you lost your job.
Using an LHRH agonist with or without Tamoxifen after breast cancer surgery may benefit premenopausal women with ER positive early breast cancer.
Low-dose estradiol worked as well as high-dose but had fewer side effects for postmenopausal women with hormone-sensitive metastatic breast cancer resistant to aromatase inhibitor therapy.